Evidence map›Paper›PMID 32271766›Full record

ArticlePloS one2020

Phenogenon: Gene to phenotype associations for rare genetic diseases.

Nikolas Pontikos, Cian Murphy, Ismail Moghul, Gavin Arno, Kaoru Fujinami, Yu Fujinami, Dayyanah Sumodhee, Susan Downes, Andrew Webster, Jing Yu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Nikolas PontikosUCL Genetics Institute, University College London, London, United Kingdom.ORCID 0000-0003-1782-4711
Cian MurphyUCL Genetics Institute, University College London, London, United Kingdom.ORCID 0000-0003-1356-959X
Ismail MoghulUCL Cancer Institute, University College London, London, United Kingdom.ORCID 0000-0003-3653-2327
Gavin ArnoInstitute of Ophthalmology, University College London, London, United Kingdom.
Kaoru FujinamiInstitute of Ophthalmology, University College London, London, United Kingdom.
Yu FujinamiGraduate School of Health Management, Keio University, Tokyo, Japan.
Dayyanah SumodheeQueen Mary University, Mile End Road, Bethnal Green, London, United Kingdom.
Susan DownesOxford Eye Hospital, West Wing, John Radcliffe Hospital, Oxford, United Kingdom.
Andrew WebsterInstitute of Ophthalmology, University College London, London, United Kingdom.
Jing YuNuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.ORCID 0000-0001-8001-8494
UK Inherited Retinal Dystrophy Consortium, Phenopolis Consortium
John Radcliffe Hospital · GBKeio University · JPMoorfields Eye Hospital · GBCRUK Lung Cancer Centre of Excellence · GBQueen Mary University of London · GBTokyo Medical Center · JPUniversity of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M009513/1British Heart FoundationDepartment of HealthMedical Research CouncilWellcome Trust
6 · The paper itself

Abstract

As high-throughput sequencing is increasingly applied to the molecular diagnosis of rare Mendelian disorders, a large number of patients with diverse phenotypes have their genetic and phenotypic data pooled together to uncover new gene-phenotype relations. We introduce Phenogenon, a statistical tool that combines, Human Phenotype Ontology (HPO) annotated patient phenotypes, gnomAD allele population frequency, and Combined Annotation Dependent Depletion (CADD) score for variant pathogenicity, in order to jointly predict the mode of inheritance and gene-phenotype associations. We ran Phenogenon on our cohort of 3,290 patients who had undergone whole exome sequencing. Among the top associations, we recapitulated previously known, such as "SRD5A3-Abnormal full-field electroretinogram-recessive" and "GRHL2 -Nail dystrophy-recessive", and discovered one potentially novel, "RRAGA-Abnormality of the skin-dominant". We also developed an interactive web interface available at https://phenogenon.phenopolis.org to visualise and explore the results.

Indexed as

Genetic Association StudiesGenetic Diseases, InbornHigh-Throughput Nucleotide SequencingRare Diseases3-Oxo-5-alpha-Steroid 4-DehydrogenaseCohort StudiesComputational BiologyDatabases, GeneticDNA-Binding ProteinsExome SequencingGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansMembrane ProteinsMonomeric GTP-Binding Proteins3-Oxo-5-alpha-Steroid 4-DehydrogenaseDNA-Binding ProteinsGRHL2 protein, humanMembrane ProteinsMonomeric GTP-Binding ProteinsRRAGA protein, humanSRD5A3 protein, humanTranscription Factors

Identifiers

PMID32271766
PMCPMC7144978
OpenAlexW3016206792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.